Chloramphenicol Sodium Succinate from Japan
Water-soluble sodium succinate salt derivative of chloramphenicol, used for intravenous administration in critical infections. Falls under HTS 2941.40.00.00 as a salt of chloramphenicol per chapter note 5(C)(1) classifying organic salts with parent compounds. Essential for hospital antibiotic therapy.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include lyophilized vial specifications and reconstitution instructions; FDA requires bulk API sterility validation
• Monitor pH stability (6.4-7.2); improper storage causes succinate hydrolysis reverting to insoluble base
• Separate from human-use channels if veterinary grade to avoid FDA human drug import alerts